The American pet food manufacturer posted net sales of $2.22 billion (€2 billion) in the third quarter of its 2024 financial year.
J.M. Smucker attributed this increase to its cat food product Meow Mix®, the contract manufacturing sales related to the divested pet food brands and list price increases seen in the US retail pet food segment.
In its US retail pet food segment, net sales decreased 39% to $465.2 million (€429M).
Excluding $372.5 million (€343.7M) of non-comparable net sales in the year prior related to the divested pet food brands, net sales increased by $79.1 million (€72.9M), marking a 20% increase.
Volume/mix increased net sales by 13 percentage points, primarily driven by its cat food product, $24.5 million (€22.6M) of contract manufacturing sales related to the divestiture and growth for its Milk-Bone® dog snacks.
Profit and outlook
The segment saw a profit increase of $0.5 million (€0.46M), which the company attributes to higher net price realization, favorable volume/mix and lower costs, offset mainly by the impact of noncomparable segment profit in the year prior related to the divested brands and increased distribution costs.
The company’s Chair of the Board, President and CEO Mark Smucker, says the company had delivered “another quarter of strong financial results, including organic sales and earnings growth” owing to the execution of its priorities, sustained customer loyalty and volume growth across the business.
J.M. Smucker now expects its comparable net sales to rise by approximately 8.7% in 2024 compared to the previous year. Its earlier guidance was an increase of between 8.5% to 9%.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.